Annual Report of the Director 2012
The Director’s Annual Report provides an overview of the Centre’s accomplishments for the previous year and a summary of the Centre’s financial and administrative operations. The Annual Report is available in PDF form.
Prevention measures and communication strategies for hantavirus infection in Europe
Between 2000 and 2010 the annual number of reported hantavirus cases increased in Europe, although there were significant temporal and geographical fluctuations.
Estimating the annual burden of tick-borne encephalitis to inform vaccination policy, Slovenia, 2009 to 2013
Fafangel, M., Cassini, A., Colzani, E., Klavs, I., Grgič Vitek, M., Učakar, V., Muehlen, M., Vudrag, M., Kraigher, A.
Chlamydia control in Europe – a survey of Member States, 2012
This report presents the results of the second ECDC survey, carried out in 2012, to describe chlamydia prevention and control activities, changes in activities between 2007 and 2012, and suggests recommendations to improve chlamydia prevention and control in EU/EEA Member States.
Monitoring implementation of the European Commission Communication and Action Plan for combating HIV/AIDS in the European Union and neighbouring countries
ECDC’s final report on the implementation of the European Commission Communication and Action Plan to address HIV in the European Union and neighbouring countries concludes that these measures have had an important impact on HIV prevention. But additional efforts are required to further reduce HIV transmission in Europe.
Options for national testing and surveillance for hepatitis E virus in the EU/EEA - Operational guidance
This operational guidance, developed by ECDC in collaboration with its hepatitis E virus (HEV) expert group, offers options on the implementation or adjustment of HEV surveillance at a national level.
Expert opinion on priority risk groups for influenza vaccination
This paper identifies and describes population groups at increased risk for severe outcomes of influenza (“risk groups”) and advocates vaccination for two major groups, namely a) persons in the older age group, usually 65 years and older; and b) persons with chronic medical conditions.
Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe
This response plan is designed to prevent the spread of multidrug-resistant Neisseria gonorrhoeae (MDR NG) in the EU/EEA in the context of the possible emergence of untreatable gonorrhoea
Report of the joint ECDC and WHO review of the national tuberculosis programme in Bulgaria
This report outlines the results of the joint ECDC and WHO review of the Bulgarian National Tuberculosis Control Programme.
Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011
Pharris, A., Wiessing, L., Sfetcu, O., Hedrich, D., Botescu, A., Fotiou, A., Nikolopoulos, G.K., Malliori, M., Salminen, M., Suk, J.E., Griffiths, P., van de Laar, M.J.